Drug intelligence / Profile preview

Myer's Coc

Development stage: Preclinical
Lead developer: Kwang Dong Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

Myer's Coc is an oral tablet formulation of the Myers' Cocktail, developed by Kwang Dong Pharmaceutical for vitamin supplementation. Traditionally administered as an intravenous (IV) infusion, the Myers' Cocktail is a nutrient blend typically composed of magnesium, calcium, B-complex vitamins (including B1, B2, B3, B5, B6, and B12), and vitamin C. This oral version aims to provide the therapeutic benefits of these essential nutrients in a more accessible and convenient dosage form. It is currently in development for general nutritional support and addressing vitamin deficiencies, representing a transition of the traditional clinical nutrient therapy into a solid oral dosage form.

Brand names: Myer's Coc
Other names: Myers' Cocktail tabletMyer's Coc tablet

Beyond the preview

Go deeper on Myer's Coc.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myer's Coc.

Explore the full profile